The oral-contraceptive interaction is a separate study (GPGR), reported in the FDA Mounjaro NDA 215866 summary review: a single 5 mg tirzepatide dose with a combination oral contraceptive (0.035 mg ethinyl estradiol / 0.25 mg norgestimate) reduced the Cmax of norelgestromin and ethinyl estradiol by 55% to 59% a range spanning both analytes, not a separate figure for each with AUC lowered 28.8% (norelgestromin) and 27% (ethinyl estradiol), and tmax delayed 2.5 to 4.5 hours
If youre pregnant, breastfeeding, on medications, or managing a chronic condition, well talk through whether this therapy is right for youor modify it to fit your needs
Promotes endothelial cell tubule networks in Matrigel, enabling clear quantification of new capillary structures
Phelan SM, Bauer KW, Bradley D, Bradley SM, Haller IV, Mundi MS, et al
IV Therapy is much more effective at getting your body the vitamins and minerals you need